Drug Topics
MARCH 17, 2023
There was a lower probability of initiating psycholeptics and experiencing postpartum psychiatric emergencies in study patients who continued using antidepressants
STAT
MARCH 17, 2023
ST. LOUIS — It’s been eight months since Kirsten Bibbins-Domingo, a general internist, cardiovascular researcher, and epidemiologist became the 17th editor in chief of the Journal of the American Medical Association and its network of journals. Bibbins-Domingo, who previously worked at the University of California, San Francisco, was named this week as a member of the 2023 STATUS List of people making a difference in health care and life sciences.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
MARCH 17, 2023
Polio prevalence has been reduced by 99.99% in the past 35 years. But the disease continues to exist in countries like Pakistan and Afghanistan, where it seeds outbreaks elsewhere.
PharmaVoice
MARCH 17, 2023
Dr. Ryan Saadi, CEO of Tevogen Bio, is making good on a lifelong goal of bringing T cell therapies to people who need them.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
MARCH 17, 2023
Your weekly roundup of the latest news from Drug Topics®.
STAT
MARCH 17, 2023
Around 4:30 p.m. last Friday, Ketamine Wellness Centers CEO Kevin Nicholson sent an email: In 30 minutes, the company would no longer be in business, he said. The message went out to some patients and to all of the employees of his company’s clinics across nine states — what had, up until moments before, been one of the largest ketamine clinic chains in the country.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Healthcare
MARCH 17, 2023
#FierceMadness: The competition to determine healthcare's most powerful person is back!
Drug Topics
MARCH 17, 2023
A combination of dabrafenib with trametinib was approved by the FDA for treatment of pediatric patients 1 year and older with low-grade glioma & BRAF V600E mutation who require systemic therapy.
Fierce Healthcare
MARCH 17, 2023
The ACA slimmed coverage gaps between racial and ethnic groups: study pminemyer Fri, 03/17/2023 - 16:21
European Pharmaceutical Review
MARCH 17, 2023
In a first-of-its-kind commercial agreement, Great Ormond Street Hospital NHS Foundation Trust (GOSH) will work with Leucid Bio to manufacture LEU011, a lateral Chimeric Antigen Receptor (CAR) targeting NKG2D ligands. The CAR T therapy will be used in clinical studies for solid tumours and haematological malignancies. Under the agreement the parties will work together at state-of-the-art cleanroom facilities at the Zayed Centre for Research into Rare Disease in Children.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare
MARCH 17, 2023
North Carolina Blues plan says food-as-medicine program resulted in better outcomes for diabetes patients fdiamond Fri, 03/17/2023 - 15:06
Pharmaceutical Technology
MARCH 17, 2023
As the field of digital therapeutics continues to broaden, specific uses in mental health and neurology are increasingly making headway for patients and on the market. At the same time, experts are saying developers in the field need to double down on securing clinical data to allow for its continued maturation. Companies are testing the use of digital platforms along with pharmacological treatments.
Fierce Healthcare
MARCH 17, 2023
House lawmakers seek to ban spread pricing in Medicaid in latest PBM reform effort rking Fri, 03/17/2023 - 16:25
STAT
MARCH 17, 2023
The already beleaguered U.S. health care system is facing a new and costly threat that will affect patient care and ultimately may lead to hospital closures : paying for and processing a torrent of medical record requests. While the news media in 2022 focused on hospitals’ billions of dollars of losses , negative operating margins, and other daunting post-pandemic challenges , a set of costly modifications to the HIPAA Privacy Rule proposed by the Department of Health and Human Services m
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmaceutical Technology
MARCH 17, 2023
Pharmanovia and Aeterna Zentaris have entered an exclusive licensing agreement for the latter’s medicine Ghryvelin (macimorelin). Under the deal, Pharmanovia will acquire the exclusive rights and license to commercialise Ghryvelin in the EEA and the UK from Consilient Health. Ghryvelin is used for the diagnosis of Adult Growth Hormone Deficiency (AGHD), a rare and serious condition, as well as for Childhood Onset Growth Hormone Deficiency (CGHD), if approved.
STAT
MARCH 17, 2023
After more than a decade as an OB-GYN, Darine El-Chaâr still finds late-stage emergency C-sections to be hard. Labor can drag on for days without a baby being born, at which point the situation grows dangerous. “Many times I walk to the operating room, and I’m like, I’m so sorry that you got so far and now this is where you are,” said El-Chaâr, a physician at the Ottawa Hospital Research Institute.
Pharmaceutical Technology
MARCH 17, 2023
Over the last twenty years, there has been a major rise in risk sharing agreements in the pharmaceutical space, said Alex Watt, GlobalData’s principal research analyst, at a recent webinar on the same topic. These agreements have been particularly propelled by the recent rise in inflationary pressures and pharmaceutical market instability, pushing healthcare systems to find new ways to reduce risks associated with new drugs.
The Checkup by Singlecare
MARCH 17, 2023
Similar to Ozempic, Mounjaro (tirzepatide) is a medication approved to treat Type 2 diabetes. It is prescribed alongside exercise and a balanced diet to manage high blood sugar levels. After its approval in 2022, healthcare providers also prescribed Mounjaro off-label for weight loss. When living with diabetes or trying to lose weight, there are special considerations around alcohol—how it affects your blood sugar and your waistline.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
MARCH 17, 2023
At SXSW 2023, OpenAI's Greg Brockman and 23andMe's Anne Wojcicki dive into the potential for AI in healthcare hlandi Fri, 03/17/2023 - 13:16
STAT
MARCH 17, 2023
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is exceedingly modest. We plan to promenade with the official mascot, catch up on our napping, and hope to have a listening party with Mrs. Pharmalot. So far, the rotation includes this , this and this.
European Pharmaceutical Review
MARCH 17, 2023
The Medicines and Healthcare products Regulatory Agency (MHRA) ’s UK Stem Cell Bank is trialling an innovative new robot that grows stem cells. “The UK is only the second country where this technology has been tested” The MHRA’s UK Stem Cell Bank is testing the stem cell propagation robot over a 12-month period to see whether the cells produced by the fully automated Intelligent Cell Processing System meet the standards needed for them to be used in the manufacture of potentially life-savi
The Checkup by Singlecare
MARCH 17, 2023
If you’ve ever experienced dry, red, burning, itchy, or watery eyes, you know you need fast relief when this allergy symptom hits. Thankfully, there are many effective treatments. In fact, there are so many options that it can be overwhelming to narrow it down to the best allergy medicine for itchy eyes. Here, learn what your options are, along with expert advice on how to pick the most effective itchy eye medication for you.
European Pharmaceutical Review
MARCH 17, 2023
The Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for VYVGART ® (efgartigimod alfa-fcab). It is the first neonatal Fc receptor (FcRn) blocker to be approved in the UK for adults with generalised myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive. VYVGART is the first neonatal Fc receptor (FcRn) blocker to be approved in the UK for adults with generalised myasthenia gravis (gMG) who are anti-acetylcholine receptor
The Checkup by Singlecare
MARCH 17, 2023
On March 10, the U.S. Food and Drug Administration approved Zavzpret, the first calcitonin gene-related peptide (CGRP) antagonist nasal spray to treat acute migraine (with or without aura) in adults. This could mean faster—and more effective—treatment for many of the 40 million people in the U.S. who experience migraine. Read on to see what we know about this new medication and when it will be available.
Drug Store News
MARCH 17, 2023
Important personnel changes you should know this week about SpartanNash, Maesa and more.
Pharmaceutical Technology
MARCH 17, 2023
The Lung Cancer Research Foundation (LCRF) has announced a new research partnership with Daiichi Sankyo and AstraZeneca. This collaboration is intended to fund up to three research grants that are focused on antibody-drug conjugates (ADCs) for improving the outcomes for lung cancer patients. ADCs are designed for targeting cancer cells specifically and selectively provide a highly potent payload that may limit healthy cells’ damage.
Drug Store News
MARCH 17, 2023
To launch its new body wash collection, which consists of 15 established and new scents and an upgraded formula, the brand is joining forces with actress Melissa Fumero.
Fierce Healthcare
MARCH 17, 2023
Thomas Jefferson University to offer master's in health professions education to support rising interest in academia agliadkovskaya Fri, 03/17/2023 - 15:38
Drug Store News
MARCH 17, 2023
Grove Wellness is an online hub that offers a curated assortment of high-quality and affordable health and wellness products, the company said.
STAT
MARCH 17, 2023
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
Drug Store News
MARCH 17, 2023
The new flavors include Cinnamon Toast Crunch and Lucky Charms.
Pharmafile
MARCH 17, 2023
Sun Pharma has decided a settlement of $75m as part of a case surrounding various pharma companies fixing their prices. Sun Pharma and subsidiary, Taro Pharmaceutical, have agreed the settlement which will end their involvement in this case. There is also a chance that this upfront sum could be adjusted upward by around $20m, depending on various clauses in the settlement agreements, according to court documents which were filed last week.
Drug Store News
MARCH 17, 2023
Bobbie Organic Gentle, slated for a late Spring 2023 launch, will be the first and only American-made, EU-style organic product with 100% lactose, the company said.
Expert insights. Personalized for you.
468 
Let's personalize your content